Lawal, Ismaheel OpeyemiMorgenstern, AlfredVorster, MarizaKnoesen, OttoMahapane, JohncyHlongwa, Khanyisile N.Maserumule, Letjie C.Ndlovu, HonestReed, Janet D.Popoola, Gbenga O.Mokoala, Kgomotso M.G.Mdlophane, A.H.Bruchertseifer, FrankSathekge, Mike Machaba2022-07-222022-08Lawal, I.O., Morgenstern, A., Vorster, M. et al. Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 49, 3581–3592 (2022). https://doi.org/10.1007/s00259-022-05778-w.1619-7089 (online)1619-7070 (print)10.1007/s00259-022-05778-whttps://repository.up.ac.za/handle/2263/86396Please read abstract in the article.en© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. The original publication is available at : https://www.springer.com/journal/259.Targeted alpha therapySuperscanSkeletal metastasesProstate cancerHematologic toxicityMetastatic castration-resistant prostate cancer (mCRPC)Actinium-225-labeled prostate-specific membrane antigen ([225Ac]Ac-PSMA-617)Postprint Article